8-K: Bausch + Lomb Bolsters Capital Structure with Upsized €675M Notes and $2.325B Term Loan Refinancing

Bausch + Lomb Corporation's subsidiaries have successfully completed an upsized €675 million senior secured notes offering and a significant credit agreement refinancing, extending maturities and enhancing financial flexibility.

Summary

• Bausch + Lomb's subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated, closed an upsized offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031.
• The notes bear interest at a rate of three-month EURIBOR (with a 0% floor) plus 3.875% per year, reset quarterly, and were sold at a price of 99.500% of the principal amount.
• The company also completed a partial refinancing of its credit agreement through a Third Amendment, establishing a new $2.325 billion Term B Loan facility maturing in 2031 and an $800 million New Revolving Credit Facility maturing in 2030.
• The New Term B Loans have an amortization rate of 1.00% per annum, with the first installment payable on September 30, 2025.
• Initial interest rates for the New Term B Loans are 4.25% for SOFR Loans and 3.25% for ABR Loans; the rate for the New Revolving Credit Facility remains consistent with the existing facility.
• Proceeds from the notes offering and New Term B Loans were used to fully repay outstanding borrowings under the existing revolving credit facility, refinance outstanding term A loans due 2027 and term B loans due 2027, and cover related fees and expenses.
• The Third Amendment includes increased financial covenant levels, adjusting the maximum first lien net leverage ratio to 5.75:1.00 (stepping down to 5.50:1.00, 5.25:1.00, and 5.00:1.00 over subsequent fiscal quarters), up from the previous 4.50:1.00.
• The Revolving Facility Test Condition was also modified, reducing the utilization threshold from 40% to 35%.

Sentiment

Score: 8

Explanation: The successful completion of an upsized notes offering and a significant credit agreement refinancing, coupled with extended maturities and increased financial flexibility (higher leverage ratio headroom), indicates a strong positive financial event for the company. The ability to secure favorable terms and upsize the offering suggests market confidence and improved debt management.

Positives

• Successful completion of an upsized €675 million senior secured notes offering, indicating strong investor demand and favorable market reception.
• Establishment of a new $2.325 billion Term B Loan facility and an $800 million New Revolving Credit Facility, providing significant liquidity and enabling comprehensive debt refinancing.
• Extension of debt maturities to 2031 for Term B Loans and 2030 for the New Revolving Credit Facility, significantly improving the company's debt maturity profile and reducing near-term refinancing risk.
• Increased financial covenant levels, with the maximum first lien net leverage ratio adjusted to 5.75:1.00 (stepping down over time) from 4.50:1.00, providing greater operational flexibility and headroom for future strategic initiatives.
• Modifications to negative covenants and other provisions in the credit agreement offer increased transaction flexibility for Bausch + Lomb and its subsidiaries.
• The refinancing fully repaid the existing revolving credit facility and outstanding term A and term B loans due 2027, streamlining the company's debt structure.

Negatives

• The notes bear a floating interest rate (three-month EURIBOR + 3.875%), exposing the company to potential increases in interest expenses if EURIBOR rises.
• The notes were sold at a discount (99.500% of principal amount), implying a slightly higher effective yield for investors compared to par.

Risks

• **Interest Rate Risk**: The floating interest rate on the new notes and term loans exposes the company to potential increases in interest expenses if benchmark rates (EURIBOR, SOFR, ABR) rise.
• **Financial Covenant Compliance**: While covenant levels were increased, failure to comply with the maximum first lien net leverage ratio (starting at 5.75:1.00 and stepping down) could trigger an Event of Default under the credit agreement.
• **Springing Maturity Provisions**: The New Revolving Credit Facility has customary springing maturity provisions, which could lead to an earlier maturity date if certain conditions related to other debt maturities are met.
• **Tax and Regulatory Consequences**: Potential material adverse tax or regulatory consequences related to providing guarantees and collateral, or material risk of personal or criminal liability for officers/directors related to fund repatriation, as noted in the indenture.
• **General Business Risks**: The document refers to 'risks and uncertainties discussed in Bausch + Lomb's filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators (including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2024 and its most recent quarterly filings),' implying broader business, financial, and operational risks.

Future Outlook

The document primarily details completed financing transactions. While it states that proceeds will be used for general corporate purposes, no specific forward-looking guidance or estimates are provided beyond the terms of the new debt instruments. The increased financial flexibility from the amended covenants suggests a more accommodating environment for future strategic actions.

Management Comments

• "Bausch + Lomb Announces Closing of Upsized 675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility."
• "The company used the net proceeds from the Notes offering and the New Term B Loans to repay in full the outstanding borrowings under its existing revolving credit facility, to refinance in full the outstanding term A loans due 2027 and term B loans due 2027 and to pay related fees and expenses."
• "The Third Amendment includes certain other modifications to the credit agreement, including increased financial covenant levels and other changes providing for additional transaction flexibility."

Industry Context

The document focuses on Bausch + Lomb's internal financing activities and does not provide specific industry context or comparisons to competitors. The transactions are primarily corporate finance events aimed at optimizing the company's capital structure.

Corporate Governance

Related Party Transactions

• The net proceeds from the notes offering and the New Term B Loans were used to repay in full the outstanding borrowings under Bausch + Lomb's existing revolving credit facility, to refinance in full its outstanding term A loans due 2027 and term B loans due 2027, and to pay related fees and expenses. This includes the repayment by the Borrower to the Parent of cash consideration as repayment of a promissory note and a return of share capital not exceeding $300,000,000, in connection with the Separation Transactions.

Stakeholder Impact

• **Shareholders**: Potential positive impact due to improved debt maturity profile, increased financial flexibility, and reduced refinancing risk, which could enhance long-term value.
• **Creditors (Existing)**: Existing lenders under the repaid revolving credit facility and refinanced term A/B loans received full repayment.
• **Creditors (New)**: New noteholders and term loan lenders are now key creditors, benefiting from secured positions and defined interest terms.
• **Employees, Customers, Suppliers**: Indirect positive impact from enhanced financial stability and operational flexibility, potentially supporting sustained business operations and strategic growth initiatives.

Next Steps

• First installment payment for New Term B Loans on September 30, 2025.
• Quarterly interest payments for the senior secured floating rate notes beginning January 15, 2026.
• Ongoing compliance with new financial covenants and debt terms as outlined in the amended credit agreement.

Key Dates

Recommendation

Keywords

Bausch + Lomb, BLCO, SEC filing, 8-K, debt offering, senior secured notes, floating rate notes, credit agreement, refinancing, term loan, revolving credit facility, EURIBOR, SOFR, ABR, financial covenants, leverage ratio, corporate finance, debt management, capital structure, pharmaceuticals, eye health